Company news

AN2 Therapeutics, Inc. news in 2025

AN2 Therapeutics, Inc.'s news releases, calls and decks from 2025, newest first.

View company

AN2 Therapeutics Reports Third Quarter 2025 Financial Results and Recent Business and Scientific Highlights

November 12, 2025

AN2 Therapeutics Announces Research Collaboration With GSK to Advance Boron-Based LeuRS-Inhibitors Targeting Tuberculosis (TB)

November 10, 2025

AN2 Therapeutics to Participate in Fireside Chat at Evercore HealthCONx Conference

November 6, 2025

AN2 Therapeutics Reports Second Quarter 2025 Financial Results and Recent Business and Scientific Highlights

August 12, 2025

AN2 Therapeutics Commences First-in-Human Clinical Trial of Oral AN2-502998 for Chagas Disease

August 12, 2025

AN2 Therapeutics and DNDi Collaborate on Clinical Development of Promising New Oral Compound to Treat Chronic Chagas Disease

July 23, 2025

AN2 Therapeutics Reports Key Insights from 200-Patient Observational Study in Acute Melioidosis, Laying Groundwork for Phase 2 Proof-of-Concept Trial of Epetraborole

June 30, 2025

AN2 Therapeutics Announces Poster Presentation Highlighting M. Abscessus Data at 2025 Colorado Mycobacteria Conference

May 29, 2025

AN2 Therapeutics Reports First Quarter 2025 Financial Results and Recent Business and Scientific Highlights

May 13, 2025

AN2 Therapeutics Reports Data from the Phase 3 Portion of Previously Terminated EBO-301 Study and Outlines Future Milestones from Boron Chemistry Pipeline

May 1, 2025

AN2 Therapeutics to Participate in Citizens JMP Life Sciences Conference

April 30, 2025

AN2 Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business and Scientific Highlights

March 25, 2025

AN2 Therapeutics to Present at Leerink Partners Global Healthcare Conference

March 3, 2025

AN2 Provides Strategic Update for Phase 3 EBO-301 Trial in Treatment Refractory MAC Lung Disease

February 24, 2025

AN2 Therapeutics to Participate at Upcoming Investor Conferences

February 20, 2025

Decks in 2025